Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAGLE-J: Gepotidacin vs nitrofurantoin for uncomplicated urinary tract infection in Japanese females
jRCT2031220467Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gepotidacin in urinary tract infection (UTI) (2 arms), sponsored by GSK. Primary endpoint: Primary therapeutic response at test-of-cure visit. Started Jan 2023; status: completed.
02
Drugs
gepotidacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on jRCT2031220467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220467.